SEOM Clinical guidelines for the treatment of metastatic prostate cancer

Androgen deprivation treatment is the current standard first-line treatment for metastatic prostate cancer. For several years, docetaxel was the only treatment with a proven survival benefit for castration-resistant prostate cancer (CRPC). Since docetaxel became standard of care for men with symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassinello, J., Climent, M. A., González del Alba, A., Mellado, B., Virizuela, J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2014
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239763/
https://www.ncbi.nlm.nih.gov/pubmed/25319721
http://dx.doi.org/10.1007/s12094-014-1225-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239763/
https://www.ncbi.nlm.nih.gov/pubmed/25319721
http://dx.doi.org/10.1007/s12094-014-1225-3

Ejemplares similares